Ownership history in Arjuna Capital · 20 quarters on record
This page tracks every 13F SEC filing in which Arjuna Capital reported a position in VERTEX PHARMACEUTICALS INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,978 | -132 | -4.2% | 0.29% | $1.2M | $391.64 |
| 2025 Q2 | REDUCED | 3,110 | -890 | -22.2% | 0.36% | $1.4M | $445.20 |
| 2025 Q1 | REDUCED | 4,000 | -1,541 | -27.8% | 0.54% | $1.9M | $484.82 |
| 2024 Q4 | ADDED | 5,541 | +68 | +1.2% | 0.59% | $2.2M | $402.70 |
| 2024 Q3 | REDUCED | 5,473 | -534 | -8.9% | 0.66% | $2.5M | $465.08 |
| 2024 Q2 | ADDED | 6,007 | +50 | +0.8% | 0.76% | $2.8M | $468.72 |
| 2024 Q1 | ADDED | 5,957 | +1,339 | +29.0% | 0.71% | $2.5M | $418.01 |
| 2023 Q4 | ADDED | 4,618 | +243 | +5.6% | 0.59% | $1.9M | $406.89 |
| 2023 Q3 | ADDED | 4,375 | +29 | +0.7% | 0.54% | $1.5M | $347.74 |
| 2023 Q2 | REDUCED | 4,346 | -22 | -0.5% | 0.54% | $1.5M | $351.91 |
As of 2025 Q4 — sorted by position size